Yield10 Bioscience, Inc. (YTEN)
OTCMKTS: YTEN · Delayed Price · USD
1.680
+0.070 (4.35%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Yield10 Bioscience Stock Forecast
YTEN's stock price has decreased by -96.43% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Yield10 Bioscience stock have an average target of 54, with a low estimate of 12 and a high estimate of 96. The average target predicts an increase of 3,114.29% from the current stock price of 1.68.
Analyst Consensus: Buy
* Price targets were last updated on Feb 8, 2024.
Analyst Ratings
The average analyst rating for YTEN stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Strong Buy → Hold Downgrades $12 | Strong Buy → Hold | Downgrades | $12 | +614.29% | Feb 8, 2024 |
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 16, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $96 | Strong Buy | Reiterates | $96 | +5,614.29% | Nov 16, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $600 → $96 | Strong Buy | Maintains | $600 → $96 | +5,614.29% | Aug 17, 2023 |
| Lake Street | Lake Street | Strong Buy Maintains $288 → $72 | Strong Buy | Maintains | $288 → $72 | +4,185.71% | Aug 16, 2023 |
Financial Forecast
Revenue This Year
1.22M
from 60.00K
Increased by 1,940.00%
Revenue Next Year
2.65M
from 1.22M
Increased by 116.67%
EPS This Year
-17.39
from -43.66
EPS Next Year
-11.61
from -17.39
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 1.3M | 4.2M | 28.1M |
| Avg | 1.2M | 2.7M | 27.3M |
| Low | 1.2M | 1.2M | 26.2M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 2,000.0% | 243.1% | 959.1% |
| Avg | 1,940.0% | 116.7% | 928.8% |
| Low | 1,860.0% | -3.9% | 888.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -11.32 | -2.90 | -0.15 |
| Avg | -17.39 | -11.61 | -0.14 |
| Low | -22.84 | -19.60 | -0.14 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.